Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advances
- 28 February 2007
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1772 (2) , 243-262
- https://doi.org/10.1016/j.bbadis.2006.09.007
Abstract
No abstract availableKeywords
This publication has 156 references indexed in Scilit:
- Targeted Exon Skipping in Transgenic hDMD Mice: A Model for Direct Preclinical Screening of Human-Specific Antisense OligonucleotidesMolecular Therapy, 2004
- Prediction of Mammalian MicroRNA TargetsCell, 2003
- Pharmacological strategies for muscular dystrophyNature Reviews Drug Discovery, 2003
- Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophiesNature, 2002
- Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgeneBiochemical and Biophysical Research Communications, 2002
- Listening to silence and understanding nonsense: exonic mutations that affect splicingNature Reviews Genetics, 2002
- Dystrophic Muscle in Mice Chimeric for Expression of α5 IntegrinThe Journal of cell biology, 1998
- Caveolin‐mediated regulation of signaling along the p42/44 MAP kinase cascade in vivoFEBS Letters, 1998
- Calmodulin specifically binds three proteins of the dystrophin-glycoprotein complexBiochemical and Biophysical Research Communications, 1992
- Dystrophin-related protein in the fetal and denervated skeletal muscles of normal and mdx miceBiochemical and Biophysical Research Communications, 1991